Form 8-K - Current report:
SEC Accession No. 0001818382-25-000073
Filing Date
2025-05-13
Accepted
2025-05-13 07:36:21
Documents
16
Period of Report
2025-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K huma-20250513.htm   iXBRL 8-K 30024
2 EX-99.1 huma-20250513xexx991.htm EX-99.1 111540
7 image_0.jpg GRAPHIC 21724
  Complete submission text file 0001818382-25-000073.txt   354961

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT huma-20250513.xsd EX-101.SCH 2182
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT huma-20250513_def.xml EX-101.DEF 15875
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT huma-20250513_lab.xml EX-101.LAB 27912
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT huma-20250513_pre.xml EX-101.PRE 16602
18 EXTRACTED XBRL INSTANCE DOCUMENT huma-20250513_htm.xml XML 4176
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39532 | Film No.: 25937161
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)